Lv5
1120 积分 2024-07-29 加入
Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation
8天前
已完结
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
9天前
已完结
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial
11天前
已完结
Real-world assessment of treatment patterns and outcomes in patients with relapsed-refractory multiple myeloma in an Italian haematological tertiary care centre
15天前
已完结
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends
16天前
已完结
Therapeutic progress in relapsed/refractory multiple myeloma
16天前
已完结
Considerations regarding maintenance therapy for acute myeloid leukemia in remission
20天前
已关闭
SOHO State of the Art Updates and Next Questions |The Role of Maintenance Therapy in Acute Myeloid Leukemia
20天前
已完结
Azacitidine maintenance in AML post induction and posttransplant
23天前
已完结
Acute myeloid leukemia: a comprehensive update
23天前
已完结
皖公网安备34019202002308
